Delivery Order SPE2DB20D9354-SPE2DB24FX7Y7

Award Date 9/13/24
Potential Completion Date 10/4/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $34,211.88, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,364.16 firm fixed-price delivery order is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, with a completion date of August 20, 2024. The award is part of a larger $499,999,999 single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order for $11,136.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, with a period of performance through August 30, 2024. This award is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,712.00 firm fixed-price delivery order is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $14,920.50, is a firm fixed-price delivery order for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product. The contract is part of a larger indefinite delivery contract (IDC) under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,820.00 firm fixed-price delivery order is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, with a completion date of October 17, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $15,954.64 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 1,000 mg/20 ml vials of the pharmaceutical product PROLASTIN C, with a period of performance through November 25, 2024. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA...
This is a $17,974.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product, with a period of performance through December 9, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $22,425.70, is a firm fixed-price delivery order for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product. The contract has an ultimate completion date of October 17, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $34,656.16 firm fixed-price delivery order is for the supply of "PROLASTIN C 1,000 MG/20 ML VLS" and does not have a set-aside designation. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and...
  • SPE2DB20D9354
    Indefinite Delivery Contract
  • SPE2DB20D9354-SPE2DB24FX7Y7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,642.68 firm fixed-price delivery order is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, with an ultimate completion date of October 4, 2024.

The award is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide, including common medications, specialized drugs, and medical supplies. As a woman-owned small business, DMS Pharmaceutical Group has secured this contract without any set-aside designation, leveraging its status to provide critical pharmaceutical products to the Department of Defense.

Generated 12/13/24, 9:18 AM